Analysts Set UiPath, Inc. (NYSE:PATH) Target Price at $15.77

UiPath, Inc. (NYSE:PATH) has been given a consensus recommendation of “Hold” by the seventeen analysts that are presently covering the firm, Marketbeat Ratings reports. One research analyst has rated the stock with a sell rating, fifteen have assigned a hold rating and one has issued a buy rating on the company. The average 1-year target price among brokerages that have issued a report on the stock in the last year is $15.7692.

A number of analysts recently issued reports on the stock. Barclays lifted their price target on shares of UiPath from $16.00 to $18.00 and gave the stock an “equal weight” rating in a research note on Monday, January 12th. Canaccord Genuity Group boosted their target price on shares of UiPath from $15.00 to $19.00 and gave the stock a “buy” rating in a research report on Thursday, December 4th. Morgan Stanley upped their target price on shares of UiPath from $15.00 to $19.00 and gave the company an “equal weight” rating in a research note on Tuesday, December 9th. Wells Fargo & Company increased their price target on shares of UiPath from $12.00 to $14.00 and gave the stock an “equal weight” rating in a research report on Thursday, December 4th. Finally, Royal Bank Of Canada set a $14.00 price target on UiPath in a research note on Wednesday.

UiPath Stock Performance

NYSE:PATH opened at $11.35 on Friday. The stock has a market cap of $6.07 billion, a price-to-earnings ratio of 27.01, a price-to-earnings-growth ratio of 1.55 and a beta of 1.07. UiPath has a one year low of $9.38 and a one year high of $19.84. The business’s 50-day simple moving average is $15.29 and its 200 day simple moving average is $14.00.

UiPath (NYSE:PATH) last issued its quarterly earnings data on Wednesday, December 3rd. The company reported $0.16 earnings per share for the quarter, beating analysts’ consensus estimates of $0.14 by $0.02. UiPath had a return on equity of 3.73% and a net margin of 14.79%.The firm had revenue of $411.11 million during the quarter, compared to analyst estimates of $392.46 million. During the same quarter last year, the firm earned $0.11 EPS. UiPath’s quarterly revenue was up 15.9% on a year-over-year basis. On average, equities research analysts predict that UiPath will post -0.17 EPS for the current year.

Insider Activity at UiPath

In other news, CEO Daniel Dines sold 45,000 shares of the business’s stock in a transaction that occurred on Monday, December 8th. The stock was sold at an average price of $19.21, for a total value of $864,450.00. Following the completion of the sale, the chief executive officer directly owned 29,153,585 shares in the company, valued at approximately $560,040,367.85. The trade was a 0.15% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CFO Ashim Gupta sold 67,468 shares of the company’s stock in a transaction that occurred on Monday, January 5th. The shares were sold at an average price of $16.10, for a total value of $1,086,234.80. Following the sale, the chief financial officer directly owned 557,028 shares in the company, valued at approximately $8,968,150.80. This represents a 10.80% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. In the last quarter, insiders sold 950,048 shares of company stock valued at $15,881,744. Insiders own 23.19% of the company’s stock.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in PATH. Royal Bank of Canada grew its stake in UiPath by 8.4% during the 1st quarter. Royal Bank of Canada now owns 140,774 shares of the company’s stock worth $1,450,000 after buying an additional 10,872 shares during the last quarter. Woodline Partners LP boosted its holdings in shares of UiPath by 69.6% during the first quarter. Woodline Partners LP now owns 22,566 shares of the company’s stock valued at $232,000 after acquiring an additional 9,257 shares during the period. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC grew its position in shares of UiPath by 5.4% during the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 1,477,730 shares of the company’s stock worth $15,221,000 after acquiring an additional 75,737 shares during the last quarter. Sivia Capital Partners LLC bought a new position in shares of UiPath during the second quarter worth about $169,000. Finally, Truist Financial Corp increased its holdings in shares of UiPath by 14.5% in the 2nd quarter. Truist Financial Corp now owns 38,323 shares of the company’s stock worth $491,000 after acquiring an additional 4,855 shares during the period. Institutional investors and hedge funds own 62.50% of the company’s stock.

UiPath Company Profile

UiPath Inc provides an end-to-end automation platform that offers a range of robotic process automation (RPA) solutions primarily in the United States, Romania, the United Kingdom, the Netherlands, and internationally. The company offers a suite of interrelated software to build, manage, run, engage, measure, and govern automation within the organization. Its platform's embedded AI, ML, and NLP capabilities improve decisioning and information processing; emulate human behavior allows organizations to address a myriad of use cases; emulate human behavior allows organizations to address a myriad of use cases; multi-tenant platform enterprise deployment with security and governance and Automation Cloud, which enables customers to begin automating without the need to provision infrastructure, install applications, or perform additional configurations; intuitive interface and low-code, drag-and-drop functionality; signed to enable people and automations to work together; and tracks, measures, and forecasts the performance of automations, enables customers to gain powerful insights and generate key performance indicators with actionable metric.